<DOC>
	<DOCNO>NCT02712684</DOCNO>
	<brief_summary>In men require prostate biopsy multi-parametric ultrasound base diagnostic strategy compare multi-parametric MRI base diagnostic strategy lead similar detection clinically significant prostate cancer ?</brief_summary>
	<brief_title>Cancer Diagnosis Multiparametric UltraSound Prostate</brief_title>
	<detailed_description>Men require prostate biopsy approach consent enter study . Participants undergo pre-biopsy mp-MRI mp-USS prostate . Only men positive scan undergo prostate biopsy . The order lesion discover mp-MRI mp-USS sample randomise . All biopsy take via transperineal route single procedure . Comparison drawn biopsy result lesion detect mp-USS lesion detect mp-MRI . Consideration give whether lesion detect one imaging modality abnormality one detect image modality , patient . Analysis carry level lesion whole prostate . Men without suspicious lesion either image modality proceed biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . A potential need prostate biopsy indicate raise PSA clinical parameter , final decision take imaging . 2 . PSA &lt; /=20ng/ml measure within 6 month screen visit 3 . An understanding English language sufficient understand write verbal information trial consent process 4 . Estimated life expectancy 5 year 5 . Signed informed consent 1 . Any contraindication ultrasound contrast agent include right left shunt , pulmonary hypertension , uncontrolled hypertension adult respiratory distress syndrome . Also patient recent acute coronary syndrome unstable ischaemic heart disease . 2 . Any form hormone ( except 5alpha reductase inhibitor ) within 6 month screen visit 3 . Irreversible coagulopathy predispose bleed 4 . Inability undergo transrectal ultrasonography 5 . Prostate volume , measure time mpUSS previously unknown , &gt; 60cc . 6 . Previous radiation therapy prostate 7 . Previous HIFU , cryosurgery , thermal therapy , irreversible electroporation , photodynamic , photothermal therapy , microwave injectable toxin therapy prostate . 8 . Transurethral resection vaporization prostate benign prostatic hyperplasia use energy modality within 6 month screen visit 9 . Nodal metastatic prostate cancer form image timepoint 10 . Not fit general anaesthetic 11 . Any condition investigator considers would make patient unsuitable</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>